Cronos Group (TSE:CRON) Stock Price Down 0.3% – Here’s What Happened

Cronos Group Inc. (TSE:CRON)’s share price was down 0.3% on Tuesday . The company traded as low as C$3.92 and last traded at C$3.94. 197,661 shares traded hands during mid-day trading, an increase of 21% from the average session volume of 163,922 shares. The stock had previously closed at C$3.95.

Analyst Upgrades and Downgrades

Separately, TD raised their price objective on shares of Cronos Group from C$4.50 to C$5.50 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of C$4.75.

Cronos Group Stock Up 13.7%

The company has a 50-day simple moving average of C$3.90 and a 200 day simple moving average of C$3.70. The company has a market cap of C$1.61 billion, a P/E ratio of -188.00, a P/E/G ratio of 0.12 and a beta of 1.13. The company has a current ratio of 21.87, a quick ratio of 24.01 and a debt-to-equity ratio of 0.12.

Cronos Group (TSE:CRON) last released its earnings results on Monday, May 11th. The company reported C$0.06 earnings per share for the quarter. Cronos Group had a negative return on equity of 0.19% and a negative net margin of 1.29%.The business had revenue of C$62.86 million for the quarter. On average, equities analysts anticipate that Cronos Group Inc. will post -0.26 EPS for the current year.

Cronos Group Company Profile

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.